Bridging research and clinical practice
The Division of Experimental Pathology and Laboratory Medicine uses molecular biology, cellular biology, and genetic and epidemiological tools to better understand cancer and other conditions—discoveries leading to improved diagnosis and treatment.
Overview
The Division of Experimental Pathology and Laboratory Medicine at Mayo Clinic seeks to reveal the mechanisms underlying disease development using molecular biology, cellular biology, and genetic and epidemiological tools. The division's research advances scientific and clinical knowledge to facilitate development of new diagnostic, therapeutic and preventive measures. Experimental pathology provides the bridge between research and clinical practice; it is from basic research that new ideas emerge.
Research within the Division of Experimental Pathology and Laboratory Medicine is primarily aimed at delineating and understanding the molecular basis of cancer, including cancers of the breast, prostate, ovary, pancreas, colon, brain, pituitary, thyroid, lung, and hematologic and renal systems. Other areas of research include understanding of the basic mechanisms of fibrogenesis in renal disease.
Vision
The Division of Experimental Pathology and Laboratory Medicine's vision is to promote excellence in patient care by conducting and collaborating in clinical and basic research.
Affiliations